Bay City Capital
North America, California, United States, San Francisco
Description
Bay City Capital LLC (Bay City Capital), established in 1997 , specializes in investments in the life sciences industry.
Investor Profile
Bay City Capital has made 131 investments, with 0 in the past 12 months and 19% as lead.
Stage Focus
- Series B (24%)
- Series Unknown (21%)
- Series A (18%)
- Series C (14%)
- Post Ipo Equity (8%)
- Series D (5%)
- Seed (5%)
- Series E (3%)
- Private Equity (2%)
- Debt Financing (1%)
Country Focus
- United States (92%)
- The Netherlands (2%)
- Iceland (2%)
- Denmark (1%)
- Canada (1%)
- United Kingdom (1%)
'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
- Israel (1%)
- Ireland (1%)
'/%3e%3cpath d='M200 752.362h200v300H200z' style='fill:%23fff;fill-opacity:1;stroke:none' transform='translate(0 -752.362)'/%3e%3cpath d='M400 752.362h200v300H400z' style='fill:%23ff883e;fill-opacity:1;stroke:none' transform='translate(0 -752.362)'/%3e%3c/svg%3e)
Industry Focus
- Biotechnology
- Health Care
- Pharmaceutical
- Medical
- Therapeutics
- Health Diagnostics
- Biopharma
- Medical Device
- Genetics
- Manufacturing
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
